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Abstract: 
This paper provides a review of natural Chinese drug products, including phytochemic compounds, medicinal 
herbs and multi-component herbal formulae, that have been reported to possess hypoglycemic activity with 
mechanisms for antidiabetic action. Along with a great number of combination formulae, — 187 different 
Chinese medicinal herbs are clinically applied to treat diabetes mellitus and its complications in China, most of 
which have achieved reasonably good clinical outcomes. These valuable data and practical experience provide a 
promising opportunity for the discovery and development of drug candidates with good therapeutic efficacy and 
low toxicity. The concept of treating complex, multifactorial metabolic diseases, such as diabetes, using multi-
component therapeutics, including single-herb formulae and combination herbal formulae, shall be regarded as 
a concerted pharmacologic intervention of multiple compounds interacting with multiple targets and possessing 
interdependent activities that are required for a synergistic or optimal effect. The conventional approach for the 
discovery and development of antidiabetic drug products from natural products involving a high-throughput, 
bioactivity guided drug screening of single compounds obtained from thousands of herbs has proven to be a 
costly and non-productive effort. Hence, an alternative way of developing new drug candidates, as suggested in 
this review, is to reduce and simplify a well-established combination herbal formula, along with the 
pharmacologic evaluation of a small group of phytochemic compounds, which are therapeutically effective as 
the original formula and have known chemical structures, compositions and mechanisms of action that are 
similar to chemical drugs. 
 





According to its clinical manifestation, diabetes mellitus is categorized in traditional Chinese medicine (TCM) 
as Xiao Ke, meaning wasting and thirsting disorder. The reference to diabetes by the traditional term appears as 
early as 475 BC, in the first medical text in Chinese history, Huang Di Nei Jing, or The Yellow Emperor's Inner 
Classic. The Characteristic features of Xiao Ke are excessive thirst, hunger, urination, emotional disturbance, an 
improper diet and eating habits, overindulgent sexual activity and dryness. Depending on the TCM pattern, 
Xiao Ke is classified into three levels. The upper level is characterized by the prominence of excessive thirst 
and a dry mouth, the middle level is characterized by the prominence of excessive hunger and the lower level is 
dominated by excessive urination and lumbar pain. 
 
Diabetes mellitus is a heterogeneous endocritic disorder disease, characterized by the abnormal metabolism of 
carbohydrate, lipid and protein [1]. The long-term durative hyperglycemia usually concurs serious 
macrovascular and microangiopathy complications, which influence the patient's quality of life and leads to 
disabilities and high mortality [2-4]. Due to the rapid dietary and lifestyle alterations, the past two decades
 
 
have seen an explosive worldwide increase in the number of people that are diagnosed with diabetes mellitus. It 
is estimated that the number of people with diabetes in the world is ~ 120 million now [101] and it will rise up 
to 300 million by 2010 [5]. Unfortunately, the presently available oral hypoglycemic agents and insulin therapy 
have limitations with regard to systemic efficacy, patient compliance and adverse effects, which have promoted 
a tremendous effort worldwide in searching for alternative therapeutic approaches for this metabolic disease. 
With thousands of years of practice, TCM has much to offer to diabetic patients, with its therapeutic modalities, 
including acupuncture, moxibustion, herbal medicine, massage, nutritional therapy, Tai Chi and other therapies. 
Prediabetes or early-stage diabetes can be treated solely with TCM, whereas moderate and severe cases are best 
treated with both TCM and chemical drugs [6,7]. The integration of TCM and allopathic drugs can lead to a 
better control of the disease, resulting in a decrease in drug dosage(s), the number of medications, side effects 
and minimize the effects of adverse reactions. It may also reduce diabetic complications [8,9]. 
 
2. The existing antidiabetic chemical drugs 
Type 2 diabetes mellitus, which accounts for > 90% of all the diabetic patients in the world, is the consequence 
of a deficiency in the action of insulin due to abnormalities at the cell surface or within the cell, therefore 
resulting in a combination of defects in insulin secretion and/or action. Many oral antidiabetic agents are now 
available and are widely used for the management of Type 2 diabetic patients, with different modes of action 
and different types of side effects (Table 1). 
 
The treatment of Type 2 diabetes using these chemical drugs is complicated by several factors inherent to the 
disease process, typically insulin resistance, hyperinsulinemia, hypertension, impaired insulin secretion and 
cholesterol abnormalities etc. As a result, the chemical drugs, when used individually, often have a limited 
therapeutic effect in maintaining a normal glucose and lipid metabolism as well as a number of conditions 
associated with diabetes. In fact, the use of several of these drugs in combination is sometimes able to provide 
improved glycemic control and overall treatment efficacy. Therefore, the multifactorial pathogenicity of 
diabetes demands a multimodal therapeutic approach. Thus, future therapeutic strategies require the 
combination of various types of antidiabetic agents, including a strategy to use multi-component-based natural 
products. 
 
3. Effective compounds from nature products 
With the scientific and technological development of natural product research, many effective compounds 
related to the management of diabetes mellitus have been isolated, purified and identified, including 
polysaccharides, alkaloids and flavones terpenoids etc. [10,11]. The therapeutic mechanisms of these active 
compounds have been investigated, which involve an increase in insulin sensitivity, the promotion of synthesis 
of liver glycogen, decrease in decomposition of liver glycogen, enhancing glucose utilization in the peripheral 
tissue and protecting 13-cells in the pancreatic islets [12]. 
 
Cortex Moutan polysaccharide-2b (CMP-2b) is an active component that is isolated from Paeonia suffruticosa, 
with an average molecular weight of ~ 1.28   105 Da, which is a type of heterosaccharide consisting of 




its activity by lowering the fasting blood glucose level as well as improving diabetic symptoms, such as 
decreasing food and water intake in Wister male diabetic rats induced with STZ and a high fat diet. Meanwhile, 
some serum biochemical indices, such as triglyceride (TG), total cholesterol (Tch), insulin level and insulin 
sensitivity index, were improved after 5 weeks, implying that CMP-2b might have improved insulin sensitivity 
and the activity of the insulin receptor. The statistical methods of the t and F test was used in the experiment and 
this data is summarized in Table 2. 
 
Lycium barbarum polysaccharide (LBP-D) is an effective component that is extracted from the traditional 
Chinese herb Lycium barbarum. Acidic and neutral polysaccharides from the plant were first isolated by Ling 
Wang et al. [14] and, subsequently, evaluated in alloxan-induced diabetes mice for immune-regulative effects. 
The effects of LBP-D on lymphocytes proliferation, IL-1, IL-2 and T lymphocytes subpopulations were shown 
in Table 3, respectively. Experimental data were expressed by mice (X ± s) and the t test was used to make a 
comparison with different groups [15]. LBP-D appeared to be remarkably active in enhancing the lymphocyte 
proliferation, upregulating the T lymphocyte subsets (especially CD4
+
 [cluster of differentiation 4]), elevating 
the IL-1 and IL-2 levels and, therefore, restoring the immunnoregulatory functions of the alloxan-induced 
diabetes mice. 
 
Berberine, an isoquinoline alkaloid with antibacterial and antiviral activities, also exhibited a good diabetic 
effect in various models [16]. Berberine is isolated from a variety of plants, such as Coptis chinensis, Berberis 
aquifoliu, and Berberis ariatata, among which Coptis chinensis is the most frequently used medicinal plant in a 
number of traditional recipes for the treatment of Xiaoke and its complications. For instance, Coptis chinensis is 
the main ingredient in Xiaoke-ling tablets and Jiangtang pills, which are discussed in sections 3.1 and 3.2 of this 
review. Recently, berberine has been used to treat diabetes clinically and achieved satisfactory results, with 70% 
of patients experiencing a symptomatic improvement [17]. Weiping Liu [18] reported the use of berberine 
tablets to treat 36 patients with Type 2 diabetes, whose fasting blood glucose level were measured after 
berberine tablets were orally administered at 3.0 g/d for 1 month. The fasting blood glucose level of 15 patients 
was lowered to 7.8 ± 0.4 mmol/L, approaching the normal level, from 10.0 ± 3.5 mmol/L. The molecular 
mechanism of action on the antidiabetic effect of berberine had not been elucidated until 2006 by Z Cheng and 
colleagues who demonstrated that berberine stimulated glucose uptake in L6 myotubes [19]. In their work, 
berberine was found to stimulate glucose uptake in a time- and dose-dependent manner. The additional glucose 
uptake stimulated by berberine does not vary according to insulin concentration and cannot be affected by the 
phosphatidylinositol 3-kinase (PI3K) inhibitor. Therefore, berberine is believed to exert hypoglycemic effects 
by stimulating glucose uptake through the AMP-AMPK-p38 MAPK pathway, with little or no effect on insulin 
signaling pathways. 
 
The therapeutic mechanism of these antidiabetic compounds of plant origin is probably single-target-based, 
similar to that of chemical drugs. To date, a great number of compounds isolated from plants, animals and 
marine organisms have been characterized and extensively evaluated for their therapeutic activities against 
diabetes. However, very few of them have advanced to controlled, double-blind and multi-centered clinical 
trials where high potency and low toxicity are generally required as a prerequisite. On the other hand, the 
combination formulae of TCM, containing multiple medicinal plants that have evolved through years of clinical 
practice, are still routinely used today by medical practitioners in an attempt to improve the overall therapeutic 
efficacy and reduce side effects. It appeared that the selection of herbal ingredients in many of these multi-
component herbal formulae is proven to have a sound scientific basis through modern research and evaluation. 
The mechanism of action of most of these antidiabetic combination formulae is still unknown, although a multi-
targeted approach through a synergistic interaction in vivo is generally assumed in the treatment. The most 
frequently used combination formulae and their ingredients for the clinical treatment of diabetes are 




4. Antidiabetic combination formulae of traditional Chinese medicine 
4.1 Xiaoke-ling 
Xiaoke-ling tablets and Jiangtang pills are two antidiabetic complex formulae embodied in the 2000 Chinese 
Pharma-copeia, edition I. Xiaoke-ling tablets, which are developed from a Xiaoke-ling decoction, the base 
formula, is widely used by TCM practitioners for the treatment of diabetic conditions. The formula consists of 
10 medicinal herbs, Rehmannia glutinosa, Schisandra chinensis, Ophiopogon japonicuc, Paeonia suffluticosa, 
Astragalus membranaceus, Coptis chinensis, Poria cocos, Panax ginseng, Trichosanthes kirilowii and Lycium 
barbarum. Among them, Rehmannia glutinosa and Ophiopogon japonicuc, with the major ingredients being 
polysaccharides, are regarded as key components that exert the main therapeutic effect of the whole formula. 
Rehmannia glutinosa oligosaccharide (ROS) showed a significant hypoglycemic effect in Type 2 diabetic rats 
induced by streptozotocin (STZ). The antidiabetic mechanism of ROS was believed to be associated with an 
increase of the hepatic storage of glycogen and insulin levels and a decrease in glucose-6-phosphatase activity 
[45]. Polysaccharides from Ophiopogon japonicuc are believed to provide antidiabetic properties through the 
repairing of injured pancreatic islet 13-cells and facilitating the secretion of insulin [46]. Schisandrae chinensis, 
which is also regarded as an important component in the formula, is used to strengthen the effect of Rehmannia 
glutinosa and Ophiopogon japonicuc and, together, increases the overall symptomatic improvement for diabetic 
patients [47]. Paeonia suffluticosa, Coptis chinensis and Trichosanthes kirilowii are used to reduce the intrinsic 
factors of thirst as well as promote blood circulation. Astragalus membranaceus and Panax ginseng are the two 
ingredients used to strengthen the resistance of exogenous stimuli and stress. Astragalus polysaccharide (APS) 
mitigates renal pathologic development in STZ-induced diabetic rats [48]. Panaxadiol saponins (PDS) from 
Panax ginseng were reported to decrease the blood glucose and improve the disorder of the serum lipid and 
insulin sensitivity in diabetic rats [49]. Poria cocos and Lycium barbarum are used to regulate blood circulation 
[50] and immune function [13], respectively. All of the 1 0 herbs combined as a whole treat diabetic mellitus 





In the pharmacologic evaluation of Xiaoke-ling formula in an alloxan-induced rat model, the formula 
significantly decreased (p < 0.01) the blood glucose level and increased insulin level at a dose of 21.60 g/kg i.g., 
compared with those of a model group. Meanwhile, Xiaoke-ling treated rats showed a significantly improved 
histology of pancreatic islet and β-cell of pancreatic islet as compared with the no-treatment group. On the basis 
of these results, Xiaoke-ling is likely to be able to protect pancreatic cells, help repair and restore the function of 
the β cells of the pancreatic islet and thus increase insulin secretion [51]. A clinical evaluation of Xiaoke-ling 
was also conducted with 312 Type 2 diabetic patients at the People's Hospital of Taiyuan, Shanxi province [52]. 
Of all the patients evaluated, 118 individuals achieved a marked therapeutic effect (main clinical symptoms 
were recovered and the average fasting blood glucose level was < 6.66 mmol/L) and 181 showed an 
improvement (main clinical symptoms were significantly improved and the average fasting blood glucose level 
was < 8.25 mmol/L). 
 
4.2 Jiangtang (sugar lowering) pill 
Jiangtang pill, another clinically important hypoglycemic formula documented in the Chinese Pharmacopeia, 
consists of Panax ginseng, Astragalus membranaceus, Polygonatum kingianum, Poria cocos, Atractylodes 
macrocephala, Purariae lobata, Schisandrae chinensis, Coptis chinensis, Rheum palmatum, Glycyrrhiza 
uralensis. The formula is similar to Xiaoke-ling in its components. It was reported that polygona 
polysaccharose decreases the expression of the receptor of glycosylated end product (RGEP) mRNA in the 
brain tissue in aged diabetic rats and has a protective effect on the tissue damage caused by hyperglycemia and 
advanced glycosylated end products (AGE) [53]. Astragalus membranaceus polysaccharide-B (AMP-B) is 
found to significantly decrease the consumption of water and food, reduce the pancreatic damage and inhibit the 
atrophy of thymus and pancreas tissues in the alloxan-induced diabetic rats [54]. Puerarin, an active compound 
from Purariae lobata, displays the hypoglycemic effect by increasing the content of glucose transporter-4 
(GLUT4) protein in adipocytes of STZ-diabetic rats [55]. Chunxiu Chen et al. reported that the Jiangtang pill 
significantly (p < 0.05) decreased blood glucose level at a dose of 35.6 g/kg via oral administration in the 
alloxan-induced diabetic rat model. The total water intake and urine volume of the treated rats were reduced by 
32.6 and 31.5%, respectively. The TG, Tch and blood urea nitrogen levels decreased remarkably [56] in the 
treatment group (p < 0.05). These positive results were further validated in a clinical trial for a 6-month 
consecutive administration of the pills four times per day, where the diabetic symptoms of 35 patients of 164 
cases improved, fasting blood glucose levels were maintained < 7.2 mmol/L, postprandial hyperglycemia < 8.3 
mmol/L, whereas 69 patients experienced a moderate improvement [57]. 
 
4.3 Jianpi Huayu tablets 
Instead of traditional preparations of TCM, such as decoction, syrup (spherical), pills, some antidiabetic 
formulae have been prepared into more convenient dosage forms such as capsules, granules and tablets, which 
have all been well received by the market. One of these preparations is the Jianpi Huayu tablet, which consists 
of Panax ginseng, Astragalus membranaceus, Rehmannia glutinosa, Polygonum multiflorum, Atractylodes 
lancea, Scrophularia ningpoensis, Trichosanthes kirilowii, Artemisia scoparia, Coptis chinensis, Rheum 
palmatum, Salvia miltiorrhiza and Pheretima aspergillum. The therapeutic effects of Jianpi Huayu tablets for 
the management of diabetes with insulin resistance were observed in the Chinese medicine hospital of Jinan in 
the Shandong province [58]. Chenqin Liu et al. conducted a clinical trial for the 8-week consecutive 
administration of the tablets 3 times per day to 65 patients with Type 2 diabetes. A total of 8 patients exhibited a 
significant improvement in diabetic symptoms, in which fasting blood glucose levels were maintained < 7.2 
mmol/L, postprandial hyperglycemia less than 8.3 mmol/L, although 45 patients experienced moderate 
improvement and 12 patients had no effect. 
 
4.4 Single-herb formulae used for diabetes 
About 187 kinds of traditional Chinese herbs have been documented in the Compendium of Material Medica 
that have antidiabetic effects. Recently, several of these medicinal herbs with unique phytochemic ingredients 
and hypoglycemic potency have attracted investigators, one of which is Rheum officinale. Cuiling Huang et al. 
reported that the levels of prostaglandin Flα (PGFlα) and thrombaxane B2 (TXB2) in the renal cortex and urine 
were distinctly decreased, whereas P/T (PGF1α/TXB2) was markedly increased, close to normal levels when the 
diabetic rats were treated with the ethanol extract (1g/kg) of Rheum officinale. Furthermore, the activities of 
superoxide dismutase (SOD) and catalase (CAT) were significantly elevated, but the lactoperoxidase (LPO) 
concentration in the kidneys and urine were markedly lowered. These results clearly implied that the ethanol 
extract of Rheum officinale was beneficial for diabetic nephropathy and likely to be considered to be a candidate 
for this diabetic complication [59]. 
 
Ginseng is a well-known invigorator that can effectively strengthen the systemic regulatory network in response 
to interior and exterior stimuli [60]. Various extracts from ginseng roots, fruits and entire plants have been 
reported to be beneficial for diabetes mellitus [61]. Additionally, ginsenoside Re (a major compound of 
ginseng) was recently reported to alter the expression of serum protein in diabetic rats [62]. The protein was 
further determined as C-reactive protein (CRP), a kind of cytokine involved in the process of inflammation. 
Therefore, ginsenoside Re might alleviate the inflammatory conditions associated with insulin resistance. A 
total of 18 frequently used herbs in TCM are listed in Table 5, in which the water extract of herbs is the 
predominant form that is used for clinical treatment of diabetes. 
 
5. Conclusion 
There is no doubt that the terrestrial plants used in traditional Chinese medicine may provide the raw 
materials/lead molecules for antidiabetic drugs. A multitude of herbs, spices and combination herbal formulae 
are being used in the management of diabetes mellitus with a relatively insufficient knowledge of their 
mechanism of action as well as adverse effects and safety profiles. About 187 different Chinese medicinal 
herbs, along with combination formulae, are clinically applied to treat diabetes mellitus and its complications in 
China, most of which have achieved reasonably good clinical outcomes. This valuable data and practical 
experience provides a promising opportunity for the discovery and development of drug candidates with good 
therapeutic efficacy and low toxicity. 
 
Multiple chemical drugs have been used in compound formula, such as combination metformin and 
sulfonylurea, insulin and metformin, to treat diabetes or its complications clinically by western medicine and 
yielded better effects than the use of a single drug. TCM is usually used in this way as a multi-component 
 
 
therapeutic approach by medical practitioners, including single-herb formulae, which contain multiple 
phytochemical compounds, and combination herbal formulae. This shall be regarded as a concerted pharmacologic 
intervention of multiple compounds interacting with multiple targets and possessing interdependent activities that 
are required for a synergistic or optimal effect. The interaction between the ingredients in a multi-component 
herbal formula and the diseased state of the host might be far more complex than merely the result of a direct 
interaction that is exerted by a single chemical entity. Therefore, the conventional approach of the discovery and 
development of antidiabetic drug products, which is mainly on the basis of bioactivity guided single compound 
screening from thousands of herbs, has proven to be a non-productive direction. With modern sciences and 
emerging technologies, such as systems biology, multi-disciplinary approaches have been widely applied to study 
complex metabolic diseases, including diabetes mellitus. Recently, systems biology approaches, including 
genomics, proteomics and metabonomics, have been extensively applied to elucidate the mechanism of 
antidiabetic effects [63-65]. The authors' knowledge from drug discovery and development with single compound 
therapeutic agents and multi-component herbal agents has provided a unique overlap that may evolve a new 
approach for diabetes mellitus drug discovery and development. That is, multiple compounds with known 
structures and compositions, such as flavonoids, alkaloids and polysaccharides, extracted from a well-organized, 
therapeutically effective combination formulae, are to be combined, under the guidance of pharmacologic 
evaluation, to maximize their efficacy and minimize toxicity and to achieve an optimal therapeutic goal for 
diabetes mellitus. 
 
6. Expert opinion 
Based on the conclusions stated previously, the authors think that the discovery and development of new 
antidiabetic drugs from nature Chinese herbal products should be guided by the theory of traditional Chinese 
medicine, which takes a holistic view on diabetic conditions and the personalized treatment. Multi-component 
herbal medicines may be advantageous in that several active ingredients of different types in combination, such as 
flavonoids, alkaloids and polysaccharides, may provide a synergistic effect through multi-layer interactions in vivo 
with multiple targets associated with a hyperglycemic condition. An alternative way of developing new 
antidiabetic drug candidates is to simplify an existing herbal formula with demonstrated clinical efficacy, under the 
guidance of pharmacologic evaluation, to finally obtain a group of several phytochemic compounds that are as 
therapeutically effective as the original formula and has known chemical structures, compositions and mechanism 
of action, similar to chemical drugs. 
 
The dynamic nature of biology is not easily modeled and the treatment of a complex, multifactorial metabolic 
disease, such as diabetes, using multi-component therapeutics is more difficult to model. The concept of a linear 
drug discovery and development spectrum will be gradually replaced by an iterative process, where the knowledge 
gained by a systems biology approach is applied at various points in a continuum. Combination herbal formulae 
and combination phytochemic compounds derived from traditional formulae with a holistic therapeutic approach 
may hold the potential to become the therapeutics of choice in the future, due to the synergistic effect and dynamic 
adjustment achieved by the multiple ingredients that inhibit the causative factors at different stages, strengthen the 
impaired immune system and improve the overall symptoms and the patient's quality of life. 
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